Author index (vol. 5)

Journal Elsevier

ofAffeciiueDisorders,

363

5 (1983) 363-365

Atithor Index (Vol. 5) Abensour, P., see Jouvent, R., 141 Abou-Saleh, M.T. (Platelet MAG, personality and response to lithium Prophylaxis), 55 Abou-Saleh, M.T., see Coppen, A., 353 Abrams, N., see Waters, B., 9 Abrams, R. and Taylor, M.A. (The importance of mood-incongruent psychotic symptoms in melancholia), 179 Acosta, E., see Lechin, F., 19, 27 Agid, Y., see Jouvent, R., 141 Akiskal, H.S., Walker, P., Puzantian, V.R., King, D., Rosenthal, T.L. and Dranon, M. (Bipolar outcome in the course of depressive illness Phenomenologic, familial, and pharmacologic predictors), 115 Al-Yassiri, M.M., Ankier, S.I. and Bridges, P.K. (A double blind comparison of the efficacy and safety of trazodone and imipramine in endogenous depression), 333 Andersen, J., see Gjerris, A., 163 Ankier, S.I., see Al-Yassiri, M.M., 333 Anton, R.F., Sexauer, J.D, and Randall, C.L. (Amoxapine elevates serum prolactin in depressed men), 305 Arato, M., see Banki, C.M., 223 Arato, M., see Rihmer, Z., 293 Arocha, L., see Lechin, F., 19, 27 Aronoff, M.S., see Friedman, R.C., 37 Aror, R.C., see Meltzer, H.Y., 215 Athanassenas, G., see Frangos, E., 259 Baciewicz, G., see Yerevanian, B.I., 191 Bailey, J., see Coppen, A., 353 Banki, C.M. and Arato, M. (Amine metabolites and neuroendocrine responses related to depression and suicide), 223 Banki, C.M., see Perenyi, A., 171 Beth, P., see Gjerris, A., 163 Bellack, A.S., see Thase, M.E., 267 Bojholm, S., see Gjerris. A., 163 Bolwig, T.G., see Gjerris, A., 163 Bonnet, A.M., see Jouvent, R., 141 Bowden, C., see Frazer, A., 103

0165-0327/83/$03.00

Q 1983 Elsevier Science Publishers

Bridges, P.K., see Al-Yassiri, M.M., 333 Brunswick, D., see Frazer, A., 103 Burrows, G.D., see Norman, T.R., 147 Cadoret, R.J.,‘see Wilson, D.R., 199 Carroll, B.J., see Feinberg, M., 129 Clancy, J., see Coryell, W., 311 Clarkin, J.F., see Friedman, R.C., 37 Clemmesen, L., see Gjerris, A., 163 Connor, Y.M., see Cox, J.L., 1 Coppen. A., Abou-Saleh, M., Milln, P., Bailey, J. and Wood, K. (Decreasing lithium dosage reduces morbidity and side-effects during prophylaxis), 353 Coppen, A., see Saffec D., 289 Coppen, A., see Wood, K., 253 Corn, R., see Friedman, R.C., 37 Coryell, W., Noyes, R. and Clancy, J. (Panic disorder and primary unipolar depression A comparison of background and outcome), 311 Costello, E.J. (Information processing for decision making in depressed women - A study of subjective expected utilities), 239 Cox, J.L., Connor, Y.M., Henderson, I., McGuire, R.J. and Kendell, R.E. (Prospective study of the psychiatric disorders of childbirth by self report questionnaire), 1 Dam, H., see Mellerup, E.T., 341 Davidson, J. and Turnbull, C. (Isocarboxazid Efficacy and tolerance), 183 Dranon, M., see Akiskal, H.S., 115 Evans, N.J.R. and Whitlock, F.A. (Mortality late-onset affective disorder), 297 Extein, I., see Sternbach, H.A., 233

-

and

Feinberg, M. and Carroll, B.J. (Separation of subtypes of depression using discriminant analysis - Separation of bipolar endogenous depression from nonendogenous (‘neurotic’) depression, 129

B.V.

364

Frangos, E.. Athanassenas, G., Tsitourides, S.. Psilolignos P. and Katsanou, N. (Psychotic depressive disorder - A separate entity?), 259 Frazer, A., Ramsey, T.A., Swann, A.. Bowden, C., Brunswick, D., Garver, D. and Secunda, S. (Plasma and erythrocyte electrolytes in affective disorders), 103 Friedman, R.C., Hurt, SW., Clarkin, J.F., Corn, R. and Aronoff, M.S. (Symptoms of depression among adolescents and young adults), 37 Garver, D., see Frazer, A., 103 Garvey, M.J., Tuason, V.B., Lumry, A.E. and Hoffmann, N.G. (Occurrence of depression in the postpartum state), 97 Giles, D.E., see Rush, A.J., 281 Gjerris, A., Beth, P., Bojholm, S., Bolwig, T.G., Kramp, P., Clemmesen, L., Andersen, J., Jensen, E. and Rafaelsen, O.J. (The Hamilton Anxiety Scale - Evaluation of homogeneity and inter-observer reliability in patients with depressive disorders), 163 Gold, M.S., see Sternbach, H.A., 233 Ghmez, F., see Lechin, F., 19, 27 Goodnick, P., see Meltzer, H.Y., 215 Helms, P.M. and Smith, R.E. (Recurrent psychotic depression - Evidence of diagnostic stability), 51 Henderseon, I., see Cox, J.L., 1 Henderson, R., see Ho-Yen, D.O., 209 Hersen, M., see Thase, M.E., 267 Himmelhoch, J.M., see Thase, M.E., 167 Hoffmann, N.G., see Garvey, M.J., 97 Honori?, P., see Moller, SE., 67 Ho-Yen, D.O., Kay, D.S.G., Henderson, R., Todd, A.S. and Naylor, G.J. (Factor VII related antigen and procoagulant activity in manic-depressive patients), 209 Hurt, SW., see Friedman, R.C., 37 Jensen, E., see Gjerris, A., 163 Jouvent, R., Abensour, P., Bonnet, A.M., Widlocher, D., Agid, Y. and Lhermitte, F. (Antiparkinsonian and anti-depressant effects of high doses of bromocriptine - An independent comparison), 141 Judiesch, K., see Wilson, D.R., 199 Kahn, D., see Waters, B., 9 Katsanou, N., see Frangos, E., 259 Kay, D.S.G., see Ho-Yen, D.O., 209 Kendell, R.E., see Cox, J.L., 1

Kerry, R.K., McDermott, C.M. and Orme. J.E. (Affective disorders and cognitive performance - A clinical report), 349 King, D., see Akiskal, H.S., 115 Kirstein, L., see Sternbach, H.A.. 233 Kramp, P., see Gjerris, A., 163 Kupfer. D.J.. see Thase, M.E., 267 Larsen. O.B.. see Moller, SE.. 67 Lechin, E., see Lechin, F., 19, 27 Lechin, F., Van der Dijs. B.. Acosta, E., Gomez, F., Lechin, E. amd Arocha. L. (Distal colon motility and clinical parameters in depression), 19 Lechin, F., Van der Dijs, B., Ghmer. F., Arocha. L., Acosta, E. and Lechin, E. (Distal colon motility as a predictor of antidepressant reimipramine and sponse to fenfluramine, clomipramine), 27 Lewis, D.A. and Smith. R.E. (Steroid-induced psychiatric syndromes ~ A report of 14 cases and a review of the literature), 319 Lhermitte, F., see Jouvmt, R., 141 Lumry, A.E.. see Garvey, M.J., 97 McCalley-Whitters, M., see Nasrallah, H.A., 45 McDermott, C.M., see Kerry, R.J., 349 McGuire. R.J.. see Cox, J.L., 1 McIntyre, I.M., see Norman, T.R.. 147 Maguire, K.P., see Norman, T.R., 147 Mallon, P., see Yerevanian, B.I., 191 Marchenko, I., see Waters. B., 9 Mellerup, E.T., Dam, H., Wildschiodtz, G. and Rafaelsen. O.J. (Diurnal variation of blood glucose during lithium treatment), 341 Meltzer, H.Y., Aror, R.C. and Goodnick. P. (Effect of lithium carbonate on serotonin uptake in blood platelets of patients with affective disorders), 215 Milanese, E., see Yerevanian, B.I., 191 Milln, P., see Coppen. A., 353 Moller, S.E., Honor&, P. and Larsen, O.B. (Tryptophan and tyrosine ratios to neutral amino acids in endogenous depression - Relation to antidepressant response to amitriptyline and lithium + t_-tryptophan), 67 Narsapur, S.L. and Naylor, G.J. (Methylene blue - A possible treatment for manic depressive psychosis), 155 Nasrallah, H.A., Tippin, J. and McCalleyWhitters, M. (Neurological soft signs in manic patients - A comparison with schizophrenic and control groups). 45

365

Naylor, G.J., see Ho-Yen, D.O., 209 Naylor, G.J., see Narsapur, S.L., 155 Nolen, W.A. (Dopamine and mania ~ The effects of (runs- and cis-clopenthixol in a double-blind pilot study), 91 Norman, T.R., Burrows, G.D., Maguire. K.P., McIntyre, I.M. and Scoggins, B.A. (Maprotiline in affective illness - Plasma concentration and clinical response), 147 Noyes. R., see Coryell, W., 311 Olafsdottir. H., see Yerevanian, B.I.. 191 Orme, J.E., see Kerry, R.J., 349 Perenyi, A., Rihmer, Z. and Banki, C.M. (Parkinsonian symptoms with lithium, lithium-neuroleptic, and lithium-antidepressant treatment), 171 Pottash, A.L.C., see Sternbach. H.A., 233 Psilolignos, P., see Frangos, E.. 259 Puzantian, V.R., see Akiskal, H.S.. 115 Rafaelsen, O.J., see Gjerris. A., 163 Rafaelsen. O.J.. see Mellerup. E.T., 341 Ramsey, T.A., see Frazer, A., 103 Randall, C.L.. see Anton, R.F.. 305 Rihmer, Z., Szadoczky, E. and Arath, M. (Dexamethasone suppresion test in masked depression). 293 Rihmer, Z., see Perenyi, A., 171 Robertson, M.M., see Trimble, M.R., 81 Rosenthal, T.L., see Akiskal, H.S., 115 Rush, A.J., Weissenburger, J., Vinson, D.B. and Giles, D.E. (Neuropsychological dysfunction in unipolar nonpsychotic major depressions), 281 Russotto, J., see Yerevanian, B.I., 191 Saffer, D. and Coppen, A. (Frusemide: a safe diuretic during lithium therapy?), 289 Sagi, E., see Yerevanian, B.I., 191 Scoggins. B.A., see Norman, T.R., 147 Secunda. S.. see Frazer. A.. 103 Sexauer, J.D.. see Anton, R.F., 305 Smiley, D., see Waters, B., 9 Smith, R.E., see Helms, P.M., 51 Smith, R.E., see Lewis, D.A., 319 Sternbach. H.A., Kirstein. L., Pottash, A.L.C.,

Gold, M.S., Extein. 0. and Sweeney, D.R. (The TRH test and urinary MHPG in unipolar depression), 233 Swarm, A.. see Frazer. A., 103 Sweeney, D.R., see Sternbach, H.A., 233 Szadoczky, E., see Rihmer, Z., 293 Taylor, M.A., see Abrams. R., 179 Thase, M.E.. Hersen, M., Bellack. A.S.. Himmelhoch, J.M. and Kupfer, D.J. (Validation of a Hamilton subscale for endogenomorphic depression), 267 Tippin. J., see Nasrallah, H.A., 45 Todd, A.S., see Ho-Yen, D.O., 209 Trimble, M.R. and Robertson, M.M. (Flupenthixol in depression A study of serum levels and prolactin response), 81 Tsitourides, S., see Frangos, E., 259 Tuason, V.B., see Garvey, M.J., 97 Turnbull, C., see Davidson, J., 183 Van der Dijs, B., see Lechin, F., 19, 27 Vinson, D.B., see Rush, A.J., 281 Walker, P., see Akiskal, H.S., 115 Waters. B., Marchenko, I., Abrams, N., Smiley. D. and Kalin, D. (Assortative mating for major affective disorder). 9 Weissenburger, J., see Rush, A.J., 281 Whitlock, F.A., see Evans, N.J.R., 297 Widlocher, D., see Jouvent, R.. 141 Widmer, R.B., see Wilson, D.R.. 199 Wildschiodtz, G., see Mellerup, E.T.. 341 Wilson, D.R., Widmer, R.B., Cadoret, R.J. and Judiesch, K. (Somatic symptons ~ A major feature of depression in a family practice), 199 Wood, K. and Coppen, A. (Prophylactic lithium treatment of patients with affective disorders is associated with decreased platelet [ 3H]dihydroergocryptine binding), 253 Wood, K., see Coppen, A., 353 Yerevanian, B.I., Olafsdottir, Russotto, J., Mallon, P., Sagi, E. (Normalization sone Suppression Test hospital - Its prognostic

H., Milanese, E., Baciewicz, G. and of the Dexamethaat discharge from value), 191